drugset / Trial / NCT05994183
The Bronchiolitis in Hospitalized Infants Study
Phase 0
Withdrawn
IDeA States Pediatric Clinical Trials Network
National Institutes of Health (NIH) · collabUniversity of Nebraska · collab
NaSingle-groupOpen-labelOther
Summary
The goal of this clinical trial is to determine whether it is possible to identify, enroll, and deliver the study intervention (the corticosteroid dexamethasone) in hospitalized infants with bronchiolitis. Participants in this study will be given two doses of dexamethasone within 72 hours of enrollment, followed by 30 days of safety monitoring. Results of this feasibility pilot study may be used to inform the design of a future randomized controlled trial, whose results in turn could induce a paradigm shift in acute management of bronchiolitis.
Timeline
- Start
- 2023-10-09
- Primary completion
- 2025-03-09
- Completion
- 2025-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.6 mg/kg | Oral |